Addex Therapeutics Ltd Statistics
Share Statistics
Addex Therapeutics Ltd has 819.52K
shares outstanding. The number of shares has increased by -44.32%
in one year.
Shares Outstanding | 819.52K |
Shares Change (YoY) | -44.32% |
Shares Change (QoQ) | -42.1% |
Owned by Institutions (%) | 6.21% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 774 |
FTD / Avg. Volume | 10.07% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.3 and the forward
PE ratio is -1.53.
Addex Therapeutics Ltd's PEG ratio is
0.
PE Ratio | -0.3 |
Forward PE | -1.53 |
PS Ratio | 1.95 |
Forward PS | 1 |
PB Ratio | 2.75 |
P/FCF Ratio | -0.39 |
PEG Ratio | 0 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Addex Therapeutics Ltd.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.46,
with a Debt / Equity ratio of 0.3.
Current Ratio | 1.46 |
Quick Ratio | 1.46 |
Debt / Equity | 0.3 |
Debt / EBITDA | -0.03 |
Debt / FCF | -0.04 |
Interest Coverage | -475.83 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $70,128.39 |
Profits Per Employee | $-458,966.39 |
Employee Count | 23 |
Asset Turnover | 0.35 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -3.16% in the
last 52 weeks. The beta is 1.97, so Addex Therapeutics Ltd's
price volatility has been higher than the market average.
Beta | 1.97 |
52-Week Price Change | -3.16% |
50-Day Moving Average | 7.6 |
200-Day Moving Average | 8.47 |
Relative Strength Index (RSI) | 61.46 |
Average Volume (20 Days) | 7,690 |
Income Statement
In the last 12 months, Addex Therapeutics Ltd had revenue of 1.61M
and earned -10.56M
in profits. Earnings per share was -16.8.
Revenue | 1.61M |
Gross Profit | -5.32M |
Operating Income | -10.28M |
Net Income | -10.56M |
EBITDA | -10.23M |
EBIT | -10.53M |
Earnings Per Share (EPS) | -16.8 |
Full Income Statement Balance Sheet
The company has 3.87M in cash and 344.34K in
debt, giving a net cash position of 3.52M.
Cash & Cash Equivalents | 3.87M |
Total Debt | 344.34K |
Net Cash | 3.52M |
Retained Earnings | -360.42M |
Total Assets | 12.17M |
Working Capital | 3.18M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -7.99M
and capital expenditures -6.84K, giving a free cash flow of -8M.
Operating Cash Flow | -7.99M |
Capital Expenditures | -6.84K |
Free Cash Flow | -8M |
FCF Per Share | -0.11 |
Full Cash Flow Statement Margins
Gross margin is -329.99%, with operating and profit margins of -637.42% and -654.47%.
Gross Margin | -329.99% |
Operating Margin | -637.42% |
Pretax Margin | -654.47% |
Profit Margin | -654.47% |
EBITDA Margin | -634.16% |
EBIT Margin | -637.42% |
FCF Margin | -495.94% |